MARKET

NNVC

NNVC

Nanoviricides
AMEX
1.020
0.000
0.00%
After Hours: 1.030 +0.01 +0.98% 19:30 09/11 EDT
OPEN
1.020
PREV CLOSE
1.020
HIGH
1.040
LOW
0.9999
VOLUME
286.64K
TURNOVER
--
52 WEEK HIGH
2.230
52 WEEK LOW
0.8500
MARKET CAP
26.04M
P/E (TTM)
-2.3288
1D
5D
1M
3M
1Y
5Y
1D
NanoViricides announces registration of Phase II trial of NV-387 in ebolavirus
TipRanks · 4d ago
NanoViricides Says Phase II Clinical Trial Of NV-387 Oral Gummies As Treatment For Current Bundibugyo Ebolavirus And Other Ebola Viruses In DR Congo Registered In Pan African Clinical Trials Registry Database
Benzinga · 4d ago
Weekly Report: what happened at NNVC last week (0831-0904)?
Weekly Report · 5d ago
NanoViricides provides updateon Measles Drug Treatment Program
TipRanks · 08/31 12:45
NanoViricides Advances NV-387 Measles Treatment Toward Phase II Trials Following FDA Rare Pediatric Disease Designation
Benzinga · 08/31 12:34
Weekly Report: what happened at NNVC last week (0824-0828)?
Weekly Report · 08/31 10:31
World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency
Benzinga · 08/28 16:43
Weekly Report: what happened at NNVC last week (0817-0821)?
Weekly Report · 08/24 10:32
More
About NNVC
NanoViricides, Inc. is a clinical-stage company. The Company is engaged in developing a class of drugs that it calls nanoviricides, using a platform technology based on the application of nanomedicine technologies to the complex issues of viral diseases. Its lead drug candidate is NV-387, a broad-spectrum antiviral drug that has demonstrated activity in lethal lung infection animal model studies of Coronavirus (COVID), Respiratory Syncytial Virus, Influenza, Orthopoxvirus model for Smallpox and MPox, and even in a humanized mice model for Measles. It is focused on advancing Phase II clinical trials. Its other advanced drug candidate is NV-HHV-1 for the treatment of Shingles rash. Its NV-CoV-2 and NV-CoV-2-R are drug candidates for the treatment of COVID. Its portfolio also includes NV-HIV-1, a novel mechanism Anti-HIV Drug Candidate. Its other drug candidates include treatment for viral infections, including Dengue viruses, Ebola viruses, among others.

Webull offers NanoViricides, Inc stock information, including AMEX: NNVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NNVC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NNVC stock methods without spending real money on the virtual paper trading platform.